Cancer Disparities and Black American Representation in Clinical Trials Leading to the Approval of Oral Chemotherapy Drugs in the United States Between 2009 and 2019

Over the past 10 years, oral chemotherapy made up about half (45.6%) of all US Food and Drug Administration (FDA)–approved oncolytic and hematologic medications. Given the disparity in incidence and mortality rate because of certain cancers among Black Americans (BAs) in the United States, a review...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:JCO Oncol Pract
Main Authors: Ajewole, Veronica B., Akindele, Oyinkansola, Abajue, Uzoamaka, Ndulue, Okwuoma, Marshall, Jazzmin J., Mossi, Yhenew T.
Format: Artigo
Sprog:Inglês
Udgivet: Wolters Kluwer Health 2021
Fag:
Special Series: Disparities in Cancer Care for Black People in the United States
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8120664/
https://ncbi.nlm.nih.gov/pubmed/33974825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/OP.20.01108
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker